REG - Iofina PLC - Q3 2025 Update

IofinaAnnouncement

16/10/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251016:nRSP5617Da&default-theme=true

RNS Number : 5617D  Iofina PLC  16 October 2025

 

 

16 October 2025

 

Iofina plc

("Iofina", the "Company" or the "Group")

(AIM: IOF)

 

Q3 2025 Corporate Update

Record Quarter in Iodine Production History

 

Iofina plc, specialists in the exploration and production of iodine and
manufacturers of specialty chemical products, today provides an update
regarding its activities during Q3 2025 (the "Period").

 

In the Period, Iofina Resources produced 215.8 metric tonnes ('MT') of
crystalline iodide from its eight IOsorb® plants in Central and Northwest
Oklahoma (Q3 2024: 163.9 MT). This represents a 32% increase in production,
with 75 MT produced in September 2025 after IO#11 came online in July 2025.
With water volumes to our plants expected to remain consistent through Q4
2025, production for H2 2025 is on track to be within the production range of
400-440 MT.

 

Pricing and demand for raw iodine have remained strong. The average realised
iodine spot price is steadily above $70/kg, trending towards the
mid-seventies, and prices are expected to remain at these levels for the rest
of the year. The Company continues to experience strong demand for its
crystalline iodine, with global iodine consumption expected to approach 40,000
MT in 2025.

 

The negotiations with our IO#12 partner have entered the final stages, and we
are hopeful of signing an agreement shortly, and expect to commence the
plant's foundation work by the end of the year.

 

 

President and CEO, Dr. Tom Becker, commented:

"The Company continues to execute its growth strategy as illustrated by the
record month of September and Q3 2025 production increasing by 32% year on
year. Importantly, production has been steady across all our plants, putting
us on track for a crystalline iodine production range of 400-440 MT for the
second half of the year, and ultimately, further full-year growth.

 

"With production at IO#11 commencing in July, the Company has met its target
of building one new plant each year over the past three years. With
negotiations for IO#12 now in the later stages, we expect to continue the
delivery of a new plant for the fourth year running.

 

"With iodine prices remaining high and demand for Iofina's products only
getting stronger, the Board is excited by the current outlook for the rest of
the year and into 2026."

 

Enquiries:

 

Iofina plc

Dr. Tom Becker

CEO & President

Tel: +44 (0)20 3006 3135

 

Nomad & Broker:

Canaccord Genuity Limited

Henry Fitzgerald-O'Connor/Harry Rees

Tel: +44 (0)20 7523 8000

 

Financial PR and Media Contact:

Yellow Jersey PR Limited

Charles Goodwin/Shivantha Thambirajah

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

 

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated company that specialises in
the production of Iodine and the manufacturing of specialty chemical products.
Iofina is the second largest producer of iodine in North America and operates
the manufacturing entities Iofina Resources and Iofina Chemical.

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns, and operates iodine extraction plants
using Iofina's WET® IOsorb® technology. Iofina operates eight IOsorb®
plants in Oklahoma and consistently uses technology and innovation to improve
and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high-quality halogen speciality chemicals
derived from raw iodine, as well as non-iodine-based products. Iofina
Chemical celebrated its 40(th) anniversary in 2023 as a preeminent
halogen-based specialty chemicals company.

 

www.iofina.com (http://www.iofina.com/)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDFLFSRIRLELIE



            Copyright 2019 Regulatory News Service, all rights reserved